Clinical trial · Interventional
Human Papilloma Virus (HPV) Self-collection and Women Adherence
Effect of HPV Self-collection in Adherence to Cervical Cancer Screening Algorithms
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Despite declining mortality in high-income countries, cervical cancer continues to be a public health problem in low and middle -income countries. HPV tests have shown a better sensibility and a higher capacity of reducing mortality than cytology based-screening. Greater participation has been demonstrated with the use of HPV self-testing when it is offered to women with a poor screening history; however, it is not clear whether getting tested necessarily translates into a greater adherence to the entire clinical protocol, including diagnosis and treatment of precancerous lesions. The aim of this study is to evaluate the effect of the self-testing techniques on the participation and adherence of women to cervical cancer screening.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| HPV Infection | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CERVICAL HPV | Diagnostic Test | — | UNRESOLVED |
| SELF SAMPLING HPV | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- CERVICAL HPV
- description
- Routine screening procedure based on HPV tests with cervical sampling by a health personnel
- interventionNames
- Diagnostic Test: CERVICAL HPV
- type
- EXPERIMENTAL
- label
- SELF SAMPLING HPV ARM 2
- description
- Screening based on HPV self-testing and colposcopic evaluation
- interventionNames
- Diagnostic Test: SELF SAMPLING HPV
- type
- EXPERIMENTAL
- label
- SELF SAMPLING HPV ARM 3
- description
- Arm 3: screening based only on HPV self-testing
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 30 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Women 30-65 years old * No history of cytology or any other screening test for cancer of the cervix in the past 5 years * Be linked to one of the health providing entities participating in the study * Women who sign the informed consent. Exclusion Criteria: * Women 30-65 years old * No history of cytology or any other screening test for cancer of the cervix in the past 5 years * Be linked to one of the health providing entities participating in the study * Women who sign the informed consent.
References
Publications (0)
Data not yet available